These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts. Ryckwaert F; Colson P; Guillon G; Foëx P Pharmacol Res; 2005 Jun; 51(6):497-502. PubMed ID: 15829428 [TBL] [Abstract][Full Text] [Related]
7. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia. Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004 [TBL] [Abstract][Full Text] [Related]
8. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226 [TBL] [Abstract][Full Text] [Related]
9. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage. Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. Dandona P; Dhindsa S; Ghanim H; Chaudhuri A J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009 [TBL] [Abstract][Full Text] [Related]
11. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Saavedra JM; Ando H; Armando I; Baiardi G; Bregonzio C; Juorio A; Macova M Regul Pept; 2005 Jun; 128(3):227-38. PubMed ID: 15837532 [TBL] [Abstract][Full Text] [Related]
12. Selective Ang II (AT1) receptor blockade: a rational approach to end-organ protection in hypertension. Burnier M Int J Clin Pract Suppl; 2000 Aug; (111):9-13. PubMed ID: 15977401 [No Abstract] [Full Text] [Related]
13. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Saavedra JM Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377 [TBL] [Abstract][Full Text] [Related]
14. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system. Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883 [TBL] [Abstract][Full Text] [Related]
15. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat. Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343 [TBL] [Abstract][Full Text] [Related]
17. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system. Kurtz TW; Pravenec M Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538 [TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II in the response to endothelin-1 of goat cerebral arteries after ischemia-reperfusion. Salcedo A; Fernández N; García Villalón AL; Monge L; Narváez Sánchez R; Diéguez G Vascul Pharmacol; 2009; 50(5-6):160-5. PubMed ID: 19135174 [TBL] [Abstract][Full Text] [Related]
19. Administration of angiotensin II in the paraventricular nucleus protects gastric mucosa from ischemia-reperfusion injury. Zhang YM; Wei EQ; Hu X; Xu M; Shi Y; Zhang JF Brain Res; 2008 May; 1212():25-34. PubMed ID: 18445492 [TBL] [Abstract][Full Text] [Related]
20. Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma*. Timaru-Kast R; Wyschkon S; Luh C; Schaible EV; Lehmann F; Merk P; Werner C; Engelhard K; Thal SC Crit Care Med; 2012 Mar; 40(3):935-44. PubMed ID: 21926585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]